Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.

Detalles Bibliográficos
Autores principales: Janapala, Rajesh Naidu, Patel, Jigar, Belfaqeeh, Omar, Pourmand, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206577/
https://www.ncbi.nlm.nih.gov/pubmed/34183274
http://dx.doi.org/10.1016/j.intimp.2021.107878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206577/
https://www.ncbi.nlm.nih.gov/pubmed/34183274
http://dx.doi.org/10.1016/j.intimp.2021.107878

Ejemplares similares